Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study
Latest Information Update: 30 Mar 2026
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms FOCUS
Most Recent Events
- 30 Mar 2026 New trial record